As of 2024-12-11, the Relative Valuation of PureTech Health PLC (PRTC.L) is (1,084.44) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 168.80 GBP, the upside of PureTech Health PLC based on Relative Valuation is -742.4%.
The range of the Relative Valuation is (965.88) - (1,074.52) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 35.6x - 47.9x | 44.5x |
| Forward P/E multiples | 26.9x - 39.6x | 35.4x |
| Fair Price | (965.88) - (1,074.52) | (1,084.44) |
| Upside | -672.2% - -736.6% | -742.4% |
| Date | P/E |
| 2024-12-06 | -6.13 |
| 2024-12-05 | -6.08 |
| 2024-12-04 | -6.20 |
| 2024-12-03 | -6.13 |
| 2024-12-02 | -6.16 |
| 2024-11-29 | -6.14 |
| 2024-11-28 | -6.15 |
| 2024-11-27 | -6.24 |
| 2024-11-26 | -6.10 |
| 2024-11-25 | -6.27 |
| 2024-11-22 | -6.30 |
| 2024-11-21 | -5.96 |
| 2024-11-20 | -5.96 |
| 2024-11-19 | -5.96 |
| 2024-11-18 | -6.06 |
| 2024-11-15 | -6.32 |
| 2024-11-14 | -6.39 |
| 2024-11-13 | -6.21 |
| 2024-11-12 | -6.34 |
| 2024-11-11 | -6.22 |
| 2024-11-08 | -5.77 |
| 2024-11-07 | -5.77 |
| 2024-11-06 | -5.81 |
| 2024-11-05 | -5.79 |
| 2024-11-04 | -5.89 |
| 2024-11-01 | -5.72 |
| 2024-10-31 | -5.62 |
| 2024-10-30 | -5.74 |
| 2024-10-29 | -5.72 |
| 2024-10-28 | -5.61 |
| 2024-10-25 | -5.57 |
| 2024-10-24 | -5.68 |
| 2024-10-23 | -5.77 |
| 2024-10-22 | -5.75 |
| 2024-10-21 | -5.70 |
| 2024-10-18 | -5.54 |
| 2024-10-17 | -5.63 |
| 2024-10-16 | -5.67 |
| 2024-10-15 | -5.65 |
| 2024-10-14 | -5.60 |
| 2024-10-11 | -5.58 |
| 2024-10-10 | -5.55 |
| 2024-10-09 | -5.55 |
| 2024-10-08 | -5.52 |
| 2024-10-07 | -5.56 |
| 2024-10-04 | -5.52 |
| 2024-10-03 | -5.36 |
| 2024-10-02 | -5.24 |
| 2024-10-01 | -5.21 |
| 2024-09-30 | -5.40 |